Search research articles
Contact Us
Filters
Showing results (111-120 of 158) with videos related to
Page
of 16
Sort By:
Scientific Reports
|
April 8, 2025
The role of genetic testing in accurate diagnosis of X-linked sideroblastic anemia: novel ALAS2 mutations and the impact of X-chromosome inactivation
Daniel Jové-Solavera, Marta Rámila, Xènia Ferrer-Cortés, et al.
Oncogene
|
April 5, 2005
Distinct molecular phenotype of malignant CD34(+) hematopoietic stem and progenitor cells in chronic myelogenous leukemia
Ralf Kronenwett, Ulf Butterweck, Ulrich Steidl, et al.
Journal of Cancer Research and Clinical Oncology
|
April 9, 2026
High serum ferritin is associated with genetic instability in myelodysplastic neoplasms
Christina Ganster, Hannes Treiber, Gina Westhofen, et al.
International Journal of Hematology
|
January 20, 2009
Differential gene expression of bone marrow-derived CD34+ cells is associated with survival of patients suffering from myelodysplastic syndrome
Wolf C Prall, Akos Czibere, Franck Grall, et al.
Leukemia Research
|
May 14, 2021
Eligibility for clinical trials is unsatisfactory for patients with myelodysplastic syndromes, even at a tertiary referral center
Kathrin Nachtkamp, Josefine Stark, Andrea Kündgen, et al.
British Journal of Haematology
|
February 9, 2010
Prolonged survival with improved tolerability in higher-risk myelodysplastic syndromes: azacitidine compared with low dose ara-C
Pierre Fenaux, Norbert Gattermann, John F Seymour, et al.
Blood
|
July 20, 2007
Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes
Azim Mohamedali, Joop Gäken, Natalie A Twine, et al.
Blood
|
December 17, 2008
High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients
Jeffrey W Tyner, Heidi Erickson, Michael W N Deininger, et al.
Experimental Hematology
|
November 9, 2002
Reliable engraftment, low toxicity, and durable remissions following allogeneic blood stem cell transplantation with minimal conditioning
Guido Kobbe, Peter Schneider, Manuel Aivado, et al.
Oncotarget
|
July 3, 2018
Efficacy of azacitidine is independent of molecular and clinical characteristics - an analysis of 128 patients with myelodysplastic syndromes or acute myeloid leukemia and a review of the literature
Andrea Kuendgen, Catharina Müller-Thomas, Michael Lauseker, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 158) with videos related to
Sort By:
Page
of 16
Scientific Reports
|
April 8, 2025
The role of genetic testing in accurate diagnosis of X-linked sideroblastic anemia: novel ALAS2 mutations and the impact of X-chromosome inactivation
Daniel Jové-Solavera, Marta Rámila, Xènia Ferrer-Cortés, et al.
Oncogene
|
April 5, 2005
Distinct molecular phenotype of malignant CD34(+) hematopoietic stem and progenitor cells in chronic myelogenous leukemia
Ralf Kronenwett, Ulf Butterweck, Ulrich Steidl, et al.
Journal of Cancer Research and Clinical Oncology
|
April 9, 2026
High serum ferritin is associated with genetic instability in myelodysplastic neoplasms
Christina Ganster, Hannes Treiber, Gina Westhofen, et al.
International Journal of Hematology
|
January 20, 2009
Differential gene expression of bone marrow-derived CD34+ cells is associated with survival of patients suffering from myelodysplastic syndrome
Wolf C Prall, Akos Czibere, Franck Grall, et al.
Leukemia Research
|
May 14, 2021
Eligibility for clinical trials is unsatisfactory for patients with myelodysplastic syndromes, even at a tertiary referral center
Kathrin Nachtkamp, Josefine Stark, Andrea Kündgen, et al.
British Journal of Haematology
|
February 9, 2010
Prolonged survival with improved tolerability in higher-risk myelodysplastic syndromes: azacitidine compared with low dose ara-C
Pierre Fenaux, Norbert Gattermann, John F Seymour, et al.
Blood
|
July 20, 2007
Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes
Azim Mohamedali, Joop Gäken, Natalie A Twine, et al.
Blood
|
December 17, 2008
High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients
Jeffrey W Tyner, Heidi Erickson, Michael W N Deininger, et al.
Experimental Hematology
|
November 9, 2002
Reliable engraftment, low toxicity, and durable remissions following allogeneic blood stem cell transplantation with minimal conditioning
Guido Kobbe, Peter Schneider, Manuel Aivado, et al.
Oncotarget
|
July 3, 2018
Efficacy of azacitidine is independent of molecular and clinical characteristics - an analysis of 128 patients with myelodysplastic syndromes or acute myeloid leukemia and a review of the literature
Andrea Kuendgen, Catharina Müller-Thomas, Michael Lauseker, et al.
Page
of 16